These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20615077)

  • 1. DP(2) receptor antagonists in development.
    Norman P
    Expert Opin Investig Drugs; 2010 Aug; 19(8):947-61. PubMed ID: 20615077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep.
    Shichijo M; Arimura A; Hirano Y; Yasui K; Suzuki N; Deguchi M; Abraham WM
    Clin Exp Allergy; 2009 Sep; 39(9):1404-14. PubMed ID: 19486034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
    Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
    Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CRTH2 antagonists: a review of patents from 2006 to 2009.
    Ulven T; Kostenis E
    Expert Opin Ther Pat; 2010 Nov; 20(11):1505-30. PubMed ID: 20946089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel DP2 receptor antagonist (AM-461): a patent evaluation of WO2011085033.
    Norman P
    Expert Opin Ther Pat; 2011 Dec; 21(12):1931-6. PubMed ID: 22082220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation.
    Stebbins KJ; Broadhead AR; Correa LD; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
    Eur J Pharmacol; 2010 Jul; 638(1-3):142-9. PubMed ID: 20447387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation.
    Ulven T; Kostenis E
    Curr Top Med Chem; 2006; 6(13):1427-44. PubMed ID: 16918458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats.
    Hirano Y; Shichijo M; Ikeda M; Kitaura M; Tsuchida J; Asanuma F; Yanagimoto T; Furue Y; Imura K; Yasui K; Arimura A
    Eur J Pharmacol; 2011 Sep; 666(1-3):233-41. PubMed ID: 21596028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases.
    Pettipher R; Hansel TT; Armer R
    Nat Rev Drug Discov; 2007 Apr; 6(4):313-25. PubMed ID: 17396136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
    Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
    J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin D₂ induces contractions through activation of TP receptors in peripheral lung tissue from the guinea pig.
    Larsson AK; Hagfjärd A; Dahlén SE; Adner M
    Eur J Pharmacol; 2011 Nov; 669(1-3):136-42. PubMed ID: 21872585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists.
    Robarge MJ; Bom DC; Tumey LN; Varga N; Gleason E; Silver D; Song J; Murphy SM; Ekema G; Doucette C; Hanniford D; Palmer M; Pawlowski G; Danzig J; Loftus M; Hunady K; Sherf BA; Mays RW; Stricker-Krongrad A; Brunden KR; Harrington JJ; Bennani YL
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1749-53. PubMed ID: 15745833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
    Armer RE; Ashton MR; Boyd EA; Brennan CJ; Brookfield FA; Gazi L; Gyles SL; Hay PA; Hunter MG; Middlemiss D; Whittaker M; Xue L; Pettipher R
    J Med Chem; 2005 Oct; 48(20):6174-7. PubMed ID: 16190744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
    Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
    Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.
    Beaulieu C; Guay D; Wang Z; Leblanc Y; Roy P; Dufresne C; Zamboni R; Berthelette C; Day S; Tsou N; Denis D; Greig G; Mathieu MC; O'Neill G
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2696-700. PubMed ID: 18359630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R; Hansel TT
    Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Masaaki Toda
    Bioorg Med Chem; 2004 Sep; 12(17):4685-700. PubMed ID: 15358295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent CRTh2 (DP2) receptor antagonists.
    Birkinshaw TN; Teague SJ; Beech C; Bonnert RV; Hill S; Patel A; Reakes S; Sanganee H; Dougall IG; Phillips TT; Salter S; Schmidt J; Arrowsmith EC; Carrillo JJ; Bell FM; Paine SW; Weaver R
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4287-90. PubMed ID: 16753296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen.
    Yasui K; Asanuma F; Hirano Y; Shichijo M; Deguchi M; Arimura A
    Eur J Pharmacol; 2008 Jan; 578(2-3):286-91. PubMed ID: 17927976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin D2 receptor antagonists in early development as potential therapeutic options for asthma.
    Santus P; Radovanovic D
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1083-92. PubMed ID: 27409410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.